This approach revealed concentration changes in specific metabolites, such as amino acids and lipids, in the brains of depression model mice, suggesting a link to the pathophysiological changes associated with depression [405]
Journal of Medical Case Reports: Necrotizing Myopathy and Rhabdomyolysis in a Patient on Tirzepatide - Clinical documentation of rhabdomyolysis associated with tirzepatide use
(Align these procedures with 21 CFR 211.22
Psychoneuroendocrinology 131:105287 Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, Guis S, Barthelemy F, Habert P, Ceccaldi M, Million M, Raoult D, Cammilleri S, Eldin C (2021) (18) F-FDG brain pet hypometabolism in patients with long covid
Ge Z, Wu G, Ma J, Ren S, Liu T, Wu X, et al
In another clinical trial, tirzepatide reduced fasting blood glucose levels by 43.6 mg/dL to 74.4mg/dL in patients with type 2 diabetes